Obagi ®

Obagi ®
SPL v3
SPL
SPL Set ID 08ba9ea8-73fd-472b-9cc4-67df167352ec
Route
TOPICAL
Published
Effective Date 2025-03-21
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Salicylic Acid (20 mg) Titanium Dioxide (6.2 g) Zinc Oxide (15.6 g)
Inactive Ingredients
3-((l-menthyl)oxy)propane-1,2-diol Alcohol Benzyl Alcohol Chamomile Diethylene Glycol Monoethyl Ether Ext. D&c Violet No. 2 Glycerin Menthol, Unspecified Form Menthyl Lactate, (-)- Water Aluminum Oxide Caprylhydroxamic Acid Caprylyl Glycol Cetearyl Glucoside Cetostearyl Alcohol Dicaprylyl Carbonate Glycyrrhizinate Dipotassium Medium-chain Triglycerides Pentylene Glycol Polyhydroxystearic Acid (2300 Mw) Propanediol Silicon Dioxide Sodium Stearoyl Glutamate Steareth-2 Steareth-21 Stearic Acid Triethoxycaprylylsilane Trisodium Ethylenediamine Disuccinate Tropaeolum Majus Flowering Top Xanthan Gum

Identifiers & Packaging

Pill Appearance
Color: purple Color: white
Marketing Status
OTC MONOGRAPH DRUG Active Since 2021-08-01

Description

Obagi ® Medical CLENZIderm M.D. ® Pore Therapy Drug Facts

Purpose

Acne treatment


Medication Information

Purpose

Acne treatment

Description

Obagi ® Medical CLENZIderm M.D. ® Pore Therapy Drug Facts

Uses
  • or the treatment of acne
  • dries up acne pimples
  • helps prevent new acne pimples
Section 42229-5

Obagi® Medical CLENZIderm M.D.® Pore Therapy

Drug Facts

Section 50565-1

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Section 50566-9

Stop use and ask a doctor if irritation becomes severe.

Section 50567-7

When using this product keep out of eyes. Rinse with water to remove.

Section 50570-1

Do not use on damaged or broken skin

Section 55105-1
Active ingredients Purpose
Titanium dioxide 6.2% Sunscreen
Zinc oxide 15.6% Sunscreen
Warnings

For external use only

Directions
  • Cleanse the skin thoroughly before applying this product.
  • Shake product well before use.
  • Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Active Ingredient

Salicylic Acid 2%

Other Information
  • store away from heat and direct sunlight
  • store at controlled room temperature: 15°–25°C (59°–77°F)
Inactive Ingredients

benzyl alcohol, chamomilla recutita (matricaria) flower extract, ethoxydiglycol, ext. violet 2, fragrance, glycerin, menthol, menthoxypropanediol, menthyl lactate, SD alcohol 40-B, water (aqua)

Questions Or Comments?

1.800.636.7546 Monday–Friday 9a.m.–4p.m. Pacific Time

When Using This Product
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Principal Display Panel Kit Carton

SKINTRINSIQ™

CLARIFYING

PROTOCOL KIT

INCLUDES:

  • 60 Tips
  • Obagi Nu-Derm® Gentle Cleanser, 2 FL. OZ.
  • Obagi Nu-Derm® Toner, 2 FL. OZ.
  • CLENZIderm M.D.® Pore Therapy, 5 FL. OZ.
  • Obagi Hydrate® Facial Moisturizer, 1.7 OZ.
  • Obagi Sun Shield™ Mineral Broad Spectrum SPF 50 Sunscreen, 3 OZ.

OBAGI®

Principal Display Panel 85 G Tube Carton

OBAGI™

MEDICAL

Sun Shield

Broad

Spectrum

SPF 50

MINERAL

Sunscreen

Lotion

PA++++

Non-comedogenic

Dermatologist Tested

Net wt. 3 oz. (85 g)

Principal Display Panel 148 Ml Bottle Label

OBAGI®

MEDICAL

CLENZIderm M.D.®

Pore Therapy

Salicylic Acid 2%

Acne Treatment

5 FL. OZ. (148 mL)


Structured Label Content

Uses
  • or the treatment of acne
  • dries up acne pimples
  • helps prevent new acne pimples
Section 42229-5 (42229-5)

Obagi® Medical CLENZIderm M.D.® Pore Therapy

Drug Facts

Section 50565-1 (50565-1)

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Section 50566-9 (50566-9)

Stop use and ask a doctor if irritation becomes severe.

Section 50567-7 (50567-7)

When using this product keep out of eyes. Rinse with water to remove.

Section 50570-1 (50570-1)

Do not use on damaged or broken skin

Section 55105-1 (55105-1)
Active ingredients Purpose
Titanium dioxide 6.2% Sunscreen
Zinc oxide 15.6% Sunscreen
Purpose

Acne treatment

Warnings

For external use only

Directions
  • Cleanse the skin thoroughly before applying this product.
  • Shake product well before use.
  • Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Active Ingredient (Active ingredient)

Salicylic Acid 2%

Other Information (Other information)
  • store away from heat and direct sunlight
  • store at controlled room temperature: 15°–25°C (59°–77°F)
Inactive Ingredients (Inactive ingredients)

benzyl alcohol, chamomilla recutita (matricaria) flower extract, ethoxydiglycol, ext. violet 2, fragrance, glycerin, menthol, menthoxypropanediol, menthyl lactate, SD alcohol 40-B, water (aqua)

Questions Or Comments? (Questions or comments?)

1.800.636.7546 Monday–Friday 9a.m.–4p.m. Pacific Time

When Using This Product (When using this product)
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Principal Display Panel Kit Carton (PRINCIPAL DISPLAY PANEL - Kit Carton)

SKINTRINSIQ™

CLARIFYING

PROTOCOL KIT

INCLUDES:

  • 60 Tips
  • Obagi Nu-Derm® Gentle Cleanser, 2 FL. OZ.
  • Obagi Nu-Derm® Toner, 2 FL. OZ.
  • CLENZIderm M.D.® Pore Therapy, 5 FL. OZ.
  • Obagi Hydrate® Facial Moisturizer, 1.7 OZ.
  • Obagi Sun Shield™ Mineral Broad Spectrum SPF 50 Sunscreen, 3 OZ.

OBAGI®

Principal Display Panel 85 G Tube Carton (PRINCIPAL DISPLAY PANEL - 85 g Tube Carton)

OBAGI™

MEDICAL

Sun Shield

Broad

Spectrum

SPF 50

MINERAL

Sunscreen

Lotion

PA++++

Non-comedogenic

Dermatologist Tested

Net wt. 3 oz. (85 g)

Principal Display Panel 148 Ml Bottle Label (PRINCIPAL DISPLAY PANEL - 148 mL Bottle Label)

OBAGI®

MEDICAL

CLENZIderm M.D.®

Pore Therapy

Salicylic Acid 2%

Acne Treatment

5 FL. OZ. (148 mL)


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)